香烟烟雾提取物诱导RELMβ通过NF-κB/p65信号传递在慢性阻塞性肺病中的炎症
相关实验视频
Updated: Jan 11, 2026

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
7.5K
Jiaxin Lin1, Hua Liao1, Xingdong Cai1
1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Annals of clinical and laboratory science
|November 18, 2025
概括
香烟烟雾提取物 (CSE) 在慢性阻塞性肺病 (COPD) 中增加了类似抵抗素的β分子 (RELMβ). RELMβ通过NF-κB/p65通路促进炎症,有助于COPD的进展.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种渐进的肺病.
- 香烟烟雾提取物 (CSE) 是COPD发病的主要原因之一.
- 抗类分子β (RELMβ) 在COPD中CSE诱导的炎症中的作用需要进一步阐明.
研究的目的:
- 研究CSE对COPD中RELMβ表达的调控作用.
- 阐明RELMβ调节COPD炎症因子的机制.
- 通过RELMβ.65确定NF-κB/p65信号通路在CSE诱导的炎症中的参与.
主要方法:
- 在CSE暴露后,在16HBE细胞中评估了RELMβ表达.
- 在RELMβ操纵的16HBE细胞中评估了NF-κB/p65激活,IκBα降解和炎症因子表达.
- 使用NF-κB信号通路抑制剂 (pyrrolidine dithiocarbamate,Bay 11-7082) 来阻止CSE和RELMβ的影响.
主要成果:
- 在16HBE细胞中,CSE暴露提高了RELMβ的mRNA和蛋白质表达.
- 过度表达或刺激RELMβ增强了关键炎症性细胞因子 (IL-1β,IL-8,IL-6,TNF-α) 的分泌和mRNA表达.
- CSE和RELMβ激活了NF-κB/p65通路,通过增加酸化,核转位和IκBα降解来证明,这种降解被NF-κB抑制剂阻断.
结论:
- 通过调节RELMβ,从而激活NF-κB/p65信号通路,CSE诱导COPD的炎症.
- 在COPD中,RELMβ在调解CSE诱导的炎症反应方面发挥着重要作用.
- 这项研究提供了对CSE对通过RELMβ.的COPD进展的贡献背后的分子机制的新见解.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K

